Crism Therapeutics (LSE:CRTX) Total Assets : £2.42 Mil (As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Total Assets?

Crism Therapeutics's Total Assets for the quarter that ended in Jun. 2024 was £2.42 Mil.

During the past 12 months, Crism Therapeutics's average Total Assets Growth Rate was -52.00% per year. During the past 3 years, the average Total Assets Growth Rate was -75.60% per year. During the past 5 years, the average Total Assets Growth Rate was -45.00% per year. During the past 10 years, the average Total Assets Growth Rate was -13.00% per year.

During the past 13 years, Crism Therapeutics's highest 3-Year average Total Assets Growth Rate was 44.50%. The lowest was -75.60%. And the median was 5.30%.

Total Assets is connected with ROA %. Crism Therapeutics's annualized ROA % for the quarter that ended in Jun. 2024 was -0.84%. Total Assets is also linked to Revenue through Asset Turnover. Crism Therapeutics's Asset Turnover for the quarter that ended in Jun. 2024 was 0.00.

Crism Therapeutics Total Assets Historical Data

The historical data trend for Crism Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics Total Assets Chart

Crism Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

21.56

23.78

23.15

23.75

3.76

Crism Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Assets	Get a 7-Day Free Trial															31.64	23.75	6.17	3.76	2.42

Crism Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Crism Therapeutics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	3.237	+	0.52
	=	3.76

Crism Therapeutics's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	2.07	+	0.351
	=	2.42

Crism Therapeutics (LSE:CRTX) Total Assets Explanation

Total Assets is connected with ROA %.

Crism Therapeutics's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	-0.026	/	( (3.757	+	2.421)	/ 2 )
	=	-0.026	/	3.089
	=	-0.84 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Crism Therapeutics's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	0	/	( (3.757	+	2.421)	/ 2 )
=	0	/	3.089
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Crism Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Crism Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Crism Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB

Website

https://www.crismtherapeutics.com

Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines